RetroSense Therapeutics asset sale to Allergan
RetroSense Therapeutics was purchased by Allergan PLC in … with an initial payout of $60M. Expected payments thereafter exceed $550M. BlueWater Angels provided seed round funding for RetroSense in March 2014, follow-on funding in RetroSense’s B Round in 2015, and bridge funding in 2016 for a total of $2.2M invested. Syndicated investors brought this total to $15M.